Immatics (IMTX) EPS (Weighted Average and Diluted) (2021 - 2025)
Immatics' (IMTX) quarterly EPS (Weighted Average and Diluted) came in at -$79505.5 in Q2 2025, down 43428702.57% year-on-year from N/an in Q2 2024, and down 17714830.61% quarter-over-quarter from $0.45 in Q4 2024.
Immatics (IMTX) EPS (Weighted Average and Diluted) (2021 - 2025) Analysis & Trends
Immatics has disclosed EPS (Weighted Average and Diluted) across 5 years of filings, most recently posting -$79505.5 for Q2 2025.
- EPS (Weighted Average and Diluted) for Q2 2025 came in at -$79505.5, down 43428702.57% year-over-year; the trailing twelve-month figure through Jun 2025 was -$79505.5 (down 11440021.02% YoY), and the FY2025 annual result was -$1.82, down 1315.88% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$79505.5 for Q2 2025 at Immatics, down from $0.45 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $63453.3 in Q1 2022 to a low of -$79505.5 in Q2 2025.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.31 (2023), against an average of -$6146.7.
- Across the five-year window, EPS (Weighted Average and Diluted) jumped 251.87% in 2024 and sank 43428702.57% in 2025, its largest moves.
- Immatics' EPS (Weighted Average and Diluted) stood at -$0.43 in 2021, then jumped by 107.45% to $0.03 in 2022, then sank by 1017.41% to -$0.3 in 2023, then surged by 251.87% to $0.45 in 2024, then slumped by 17714830.61% to -$79505.5 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$79505.5 (Q2 2025), $0.45 (Q4 2024), and -$0.09 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -79,505.49 |
| Dec 31, 2024 | 0.45 |
| Sep 30, 2024 | -0.09 |
| Jun 30, 2024 | -0.18 |
| Mar 31, 2024 | -0.03 |
| Dec 31, 2023 | -0.30 |
| Sep 30, 2023 | -0.32 |
| Jun 30, 2023 | -42.43 |
| Dec 31, 2022 | 0.03 |
| Sep 30, 2022 | -25,408.97 |
| Jun 30, 2022 | -10,531.53 |
| Mar 31, 2022 | 63,453.33 |
| Sep 30, 2021 | -0.43 |
| Jun 30, 2021 | -34,017.95 |